Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International Journal of Molecular Sciences 24.9 (2023): 8156.
- Klassifikation
-
Biowissenschaften, Biologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2023
- Urheber
-
Cordsmeier, Arne
Jungnickl, Doris
Herrmann, Alexandra
Korn, Klaus
Ensser, Armin
- DOI
-
10.3390/ijms24098156
- URN
-
urn:nbn:de:bvb:29-opus4-232818
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cordsmeier, Arne
- Jungnickl, Doris
- Herrmann, Alexandra
- Korn, Klaus
- Ensser, Armin
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2023
Ähnliche Objekte (12)
Computational epitope map of SARS-CoV-2 spike protein
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
Charakterisierung des Spike-Proteins des schweren akuten Atemnotsyndrom Coronavirus (SARS-CoV)
Map of SARS-CoV-2 spike epitopes not shielded by glycans
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Recombinant measles viruses : use as bivalent vaccine and modulation of their membrane fusion activity
AAV-vector based vaccines for pandemic viruses: Evaluation of broadly reactive responses against influenza A viruses and SARS-CoV-2
Inhibition of Rab1B Impairs Trafficking and Maturation of SARS-CoV-2 Spike Protein
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Computational epitope map of SARS-CoV-2 spike protein
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
Charakterisierung des Spike-Proteins des schweren akuten Atemnotsyndrom Coronavirus (SARS-CoV)
Map of SARS-CoV-2 spike epitopes not shielded by glycans
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Recombinant measles viruses : use as bivalent vaccine and modulation of their membrane fusion activity
AAV-vector based vaccines for pandemic viruses: Evaluation of broadly reactive responses against influenza A viruses and SARS-CoV-2
Inhibition of Rab1B Impairs Trafficking and Maturation of SARS-CoV-2 Spike Protein
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Computational epitope map of SARS-CoV-2 spike protein
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
Charakterisierung des Spike-Proteins des schweren akuten Atemnotsyndrom Coronavirus (SARS-CoV)
Map of SARS-CoV-2 spike epitopes not shielded by glycans
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Comparative studies of recombinant oncolytic viruses for the treatment of CD133-positive tumors
Recombinant measles viruses : use as bivalent vaccine and modulation of their membrane fusion activity
AAV-vector based vaccines for pandemic viruses: Evaluation of broadly reactive responses against influenza A viruses and SARS-CoV-2
Inhibition of Rab1B Impairs Trafficking and Maturation of SARS-CoV-2 Spike Protein